InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Mickle Travis C, Chairman & CEO. Director active across 1 company, notably Kempharm, INC. Cumulatively, 5 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €80k. Activity tracked since 14 June 2021. The latest transaction was filed on 25 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Travis C. Mickle is the President and Chief Executive Officer of KEMPHARM, INC. He is responsible for the strategic and operational leadership of the company. Mickle plays a key role in innovation and product development, thereby contributing to KEMPHARM's growth.